HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bi-He Cai Selected Research

Toll-Like Receptors (Toll-Like Receptor)

1/2020BGN/TLR4/NF-B Mediates Epigenetic Silencing of Immunosuppressive Siglec Ligands in Colon Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bi-He Cai Research Topics

Disease

11Neoplasms (Cancer)
04/2023 - 01/2017
3Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2017
3Carcinogenesis
01/2020 - 01/2018
2Squamous Cell Carcinoma of Head and Neck
12/2022 - 11/2022
1Inborn Genetic Diseases (Disease, Hereditary)
11/2022
1Inflammation (Inflammations)
01/2020
1Starvation
01/2019
1Hypoxia (Hypoxemia)
01/2018

Drug/Important Bio-Agent (IBA)

4Polysaccharides (Glycans)IBA
10/2020 - 01/2018
3Sialic Acid Binding Immunoglobulin-like LectinsIBA
01/2020 - 01/2018
2Nonsense Codon (Nonsense Mutation)IBA
04/2023 - 11/2022
2LigandsIBA
01/2020 - 01/2019
1Proteins (Proteins, Gene)FDA Link
04/2023
11- (4- methylpiperazin- 1- yl)- 3- (5- nitrofuran- 2- yl)prop- 2- en- 1- oneIBA
12/2022
1Nicotinamide PhosphoribosyltransferaseIBA
12/2022
1atalurenIBA
11/2022
1Investigational DrugsIBA
11/2022
1Protein Isoforms (Isoforms)IBA
06/2022
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
10/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020
1Neuraminidase (Sialidase)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Sialyl Lewis X AntigenIBA
01/2019
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2019
1Growth Factor ReceptorsIBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1GangliosidesIBA
01/2018
1SelectinsIBA
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2017
1I-antigenIBA
01/2017

Therapy/Procedure

1Therapeutics
12/2022